Stocks
Aptevo Therapeutics Inc.APVO
NASDAQHealthcareBiotechnology$1.82-3.28%
Price as of · delayed, not real-time
Focused on developing novel immunotherapies for cancer and autoimmune diseases, this clinical-stage biotech company has a pipeline of bispecific antibody candidates. Investors monitor its progress due to high-risk/high-reward potential in oncology treatments and partnerships with larger pharma firms.
Market Cap: $7.3M52W Range: $1.37-$48.78
Congressional Interest in Aptevo Therapeutics Inc. (APVO)
1 member of Congress has disclosed 1 trade in Aptevo Therapeutics Inc. (APVO), a Healthcare company. The buy/sell breakdown shows 0 purchases versus 1 sale, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
1
Unique Politicians
1
Buys
0
Sells
1
Who in Congress Is Trading APVO?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2019-06-24 | STEVE COHEN | sell | $470+ |